Skin Diseases: Clinical Trials

31,918 trials for Skin Diseases, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

16592 completed, 4267 unknown, 3787 recruiting, 2669 terminated. 8603 Not applicable, 8344 Phase 2, 4825 Phase 1, 3556 Phase 3, 1510 Phase 4.

By phase and status

Phase	Trials	Status
Not applicable	8603	Completed 4441, Unknown 1332, Recruiting 1079, Not yet recruiting 504, Terminated 460, Active not recruiting 421, Withdrawn 275, Enrolling by invitation 68, Suspended 23
Phase 2	8344	Completed 4119, Terminated 1142, Recruiting 919, Unknown 910, Active not recruiting 509, Not yet recruiting 353, Withdrawn 343, Suspended 25, Enrolling by invitation 24
Phase 1	4825	Completed 2545, Terminated 650, Recruiting 567, Unknown 390, Active not recruiting 302, Withdrawn 191, Not yet recruiting 137, Suspended 24, Enrolling by invitation 19
Phase 3	3556	Completed 2077, Unknown 361, Recruiting 330, Terminated 278, Active not recruiting 272, Not yet recruiting 126, Withdrawn 85, Enrolling by invitation 17, Suspended 10
Phase 4	1510	Completed 857, Unknown 239, Recruiting 126, Terminated 110, Not yet recruiting 76, Withdrawn 58, Active not recruiting 33, Enrolling by invitation 11
Early Phase 1	488	Completed 211, Unknown 66, Recruiting 63, Terminated 48, Withdrawn 42, Not yet recruiting 32, Active not recruiting 18, Enrolling by invitation 6, Suspended 2

Follow Skin Diseases: new trials by email Literature Review of Skin Diseases trials Research Report on Skin Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients Skin Cleanser Combination No.1 - Atopic Dermatitis	Phase 4	Not yet recruiting	Boston Children's Hospital	100	2031-01-01	2026-03-10
Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Ivermectin Pill - Atopic Dermatitis	Phase 2	Withdrawn	Stanford University		2030-12-01	2024-12-02
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart	Phase 2	Suspended	G&E Herbal Biotechnology Co., LTD	102	2030-09-01	2023-09-14
Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis Site specific standard of care comparison - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis		Withdrawn	Massachusetts General Hospital		2030-01-01	2026-01-16
Feasibility Trial of a Culturally Tailored Resilience Intervention for Underserved Breast Cancer Survivors BRIGHT Resilience Intervention, BRIGHT Survivorship Resource Booklet - Breast Cancer, Cancer Survivorship	Not applicable	Not yet recruiting	University College Dublin	80	2029-10-01	2026-11-12
Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer DCE-MRI - Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression		Not yet recruiting	Hao Xu	400	2028-01-01	2026-02-05
Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer Resistant Potato Starch, Placebo control - Breast Cancer, HER-2 Positive Breast Cancer	Not applicable	Not yet recruiting	University of Vermont Medical Center	12	2027-10-01	2026-02-12
DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure blood sampling, Blood sampling - Renal Impairment, Digestive Cancers		Not yet recruiting	Centre Hospitalier Universitaire de Besancon	742	2027-10-01	2026-11-02
Assessment of the Prevalence of Rheumatic Heart Disease in School Settings in Mayotte and the Acquisition of Ultrasound Sequences Guided by Artificial Intelligence Ultrasound performed bycardiologis for diagnosis of rheumatic heart disease - Rheumatic Heart Diseases, Scabies	Not applicable	Not yet recruiting	Centre Hospitalier Universitaire de la Réunion	900	2027-10-01	2026-10-29
Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis Acetyl Salicylic Acid (ASA), Placebo - Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS)	Phase 3	Not yet recruiting	Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal	120	2027-10-01	2026-10-30
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases CD19-targeted iNKT Cell Injection - IgA Nephropathy (IgAN), Membranous Nephropathy	Early Phase 1	Not yet recruiting	Grit Biotechnology	30	2027-08-01	2026-09-11
Developing and Testing the Efficacy of AI-Chatbot-Based AIAI-Chatbot CalmMindRecoveryJourney delivering BMS-MC therapy - Breast Cancer	Not applicable	Not yet recruiting	National Taiwan University Hospital	68	2027-08-01	2026-08-27
Epidermal Growth Factor Receptor Inhibition for Keratinopathies Erlotinib - Epidermolytic Ichthyosis, Palmoplantar Keratoderma	Phase 1 / Phase 2	Not yet recruiting	Northwestern University	44	2027-07-01	2026-08-03
EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors EmpowerHer Hybrid Program - Breast Cancer, Cancer Survivors	Not applicable	Not yet recruiting	University of Valencia	147	2027-07-01	2026-06-30
Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer Neratinib + endocrine therapy, Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant, CDK4/6 + Endocrine therapy - Metastatic Invasive Breast Cancer, Resistant Breast Cancer	Phase 2	Not yet recruiting	University of California, San Diego	150	2027-07-01	2026-07-27
Internal Mammary Node Irradiation After Neoadjuvant Systemic Therapy for Breast Cancer Locoregional Radiotherapy With Internal Mammary Node Irradiation, Locoregional Radiotherapy Without Internal Mammary Node Irradiation - Breast Neoplasms	Phase 3	Not yet recruiting	Mahidol University	1760	2027-07-01	2026-11-13
Combination Immunotherapy Targeting Melanoma Antigen-specific CAR T, CTL and DCvac to treat melanoma. - Melanoma	Phase 1 / Phase 2	Not yet recruiting	Shenzhen Geno-Immune Medical Institute	30	2027-06-30	2026-10-30
On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer Recovery 12-week exercise regimen, 12-week standard of care - Diabetic Foot Ulcer	Not applicable	Not yet recruiting	University of Maryland, Baltimore	60	2027-06-01	2026-10-07
Korea Post Marketing Surveillance (PMS) Study of Talzenna® Talzenna - Breast Neoplasms		Withdrawn	Pfizer		2027-06-01	2026-09-14
HEADWATERS: Gemcitabine vs Paclitaxel in Metastatic Triple-Negative Breast Cancer in Women of African Ancestry. Gemcitabine (1000 mg/m^2), Paclitaxel 80 mg/m2 weekly - Triple Negative Breast Cancer, Metastatic Triple-negative Breast Cancer	Phase 2	Not yet recruiting	The University of The West Indies	750	2027-06-01	2026-09-22

Skin Diseases: Clinical Trials

31,918 trials for Skin Diseases, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

By phase and status

Trials newest first · largest first

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Results publications

NIH funding